Search Results 151-160 of 17040 for Lymphangiogenesis

  1. Mark D. Tyson, II, M.D., M.P.H. - Mayo Clinic Faculty Profiles

    Tyson II, M.D., M.P.H., mainly focuses on learning more about and treating urologic cancers, with an emphasis on surgeries for bladder cancer. These procedures ...

  2. Mayo Clinic Transplant Center - Doctors

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota.

  3. Gastroenterology and Hepatology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  4. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

    The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) ...

  5. Hodgkin lymphoma (Hodgkin disease) - Doctors and departments - Mayo Clinic

    Learn how this cancer differs from other lymphomas. Find out about risk factors and treatments, such as chemotherapy, radiation and bone marrow transplant.

  6. Hereditary hemorrhagic telangiectasia - Doctors and departments - Mayo Clinic

    This inherited blood vessel condition can cause bad nosebleeds, strokes, bleeding in the digestive tract and anemia.

  7. Doctors and departments - Mayo Clinic

    Research. Mayo Clinic doctors and researchers are studying lymphoma to look for new ways to improve diagnosis and treatment for this cancer.

  8. Hodgkin lymphoma (Hodgkin disease) - Doctors and departments - Mayo Clinic

    Learn how this cancer differs from other lymphomas. Find out about risk factors and treatments, such as chemotherapy, radiation and bone marrow transplant.

  9. A Study of the Safety and Drug/Body Interactions of BGB-3111 for Patients with B-Cell Lymphoid Malignancies - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Pulmonary Medicine Clinical Trials - Medical Professionals

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...